Filings

6 documents · 69 matches

1. TXG 10x Genomics, Inc. 10-Q 2026-11-06

   Item 1A. Risk Factors.

   tariffs and export restrictions also prompted retaliatory tariffs and export restrictions from certain countries. On February 20, 2026, the U.S. Supreme
   22 matches in this document Show context Copy citation

2. TXG 10x Genomics, Inc. 10-Q 2025-05-09

   Item 1A. Risk Factors.

   tariffs and retaliatory tariffs have been delayed, but a number of the new tariffs remain in effect, including significant tariffs
   21 matches in this document Show context Copy citation

3. TXG 10x Genomics, Inc. 10-K 2026-02-13

   Item 1A. Risk Factors.

   tariffs imposed by the United States on materials we purchase, which may negatively impact our financial results. These tariffs raise
   22 matches in this document Show context Copy citation

4. TXG 10x Genomics, Inc. 10-Q 2026-08-07

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   tariff refunds, lower inventory write-downs of $3.0 million, lower warranty costs of $2.7 million, and lower royalty costs of $0.4 million
   1 match in this document Show context Copy citation

5. TXG 10x Genomics, Inc. 8-K 2026-08-06

   tariff refunds, as well as lower inventory write-downs, partially offset by a decrease in non-recurring license and royalty
   1 match in this document Show context Copy citation

6. TXG 10x Genomics, Inc. 8-K 2025-08-07

   from customers in China accelerating purchases from the third quarter into the second quarter in anticipation of potential tariff changes.
   2 matches in this document Show context Copy citation